Trial NCT02489500

View at ClinicalTrials.gov 
Org. Study IDs: H-33808
Secondary IDs: VelRand

Last trial update was posted on 2018-09-10

MeSH Interventions

Bortezomib Lenograstim Melphalan

MeSH Conditions

Amyloidosis Immunoglobulin Light-chain Amyloidosis

Other Conditions

AL Amyloidosis

Stopping Reasons

Enrollment held for toxicity evaluation; then closed due to competing trial

Limitations And Caveats

Early termination after enrollment held for toxicity evaluation; then closed due to competing trial.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID